{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:43:46Z","timestamp":1770331426645,"version":"3.49.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1163149"],"award-info":[{"award-number":["APP1163149"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Complex regional pain syndrome (CRPS) is a rare chronic pain condition characterised by severe pain, sensory, motor, autonomic, and trophic abnormalities. Effective treatment options are limited, and international guidelines rely on low-quality evidence and consensus. Two interventions\u2014memantine, an N-methyl-D-aspartate receptor antagonist, and graded motor imagery, a rehabilitation approach targeting sensorimotor processing\u2014have shown promise in pilot studies but lack definitive evaluation in large-scale trials. MEMOIR aims to evaluate the benefits and harms of memantine and graded motor imagery for CRPS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEMOIR is a fully decentralised, 2\u2009\u00d7\u20092 factorial, randomised trial comparing memantine with placebo and graded motor imagery with no graded motor imagery in adults with CRPS. A total of 204 participants with CRPS of 6\u00a0months to 5\u00a0years duration will be randomised to one of four groups: (i) memantine and graded motor imagery, (ii) memantine only, (iii) placebo and graded motor imagery, or (iv) placebo only. Memantine will be administered at 40\u00a0mg\/day (or maximum tolerated dose); graded motor imagery will comprise seven 1-h sessions delivered via telehealth. The treatment period is 16\u00a0weeks. The dual primary outcomes are pain intensity (11-point numeric rating scale) and PROMIS pain interference assessed at 16\u00a0weeks. Secondary outcomes include physical function, fatigue, cognitive function, depressive symptoms, self-efficacy, health-related quality of life, CRPS severity, healthcare use, and adverse events. The follow-up period is 52\u00a0weeks. The estimands of interest are the mean effect of memantine compared to placebo and the mean effect of graded motor imagery compared to no graded motor imagery on all outcomes. All analyses will follow the intention-to-treat principle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>MEMOIR will be the largest investigator-initiated CRPS trial to date. The 2\u2009\u00d7\u20092 factorial design and decentralised delivery aim to maximise efficiency, accessibility, and equity. If effective, memantine and graded motor imagery represent scalable, low-cost treatments that can be given in clinics or at home, with the potential to transform CRPS management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Australian New Zealand Clinical Trials Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12621000175875\" ext-link-type=\"uri\">ACTRN12621000175875<\/jats:ext-link>\n                      ). Registered on 12 February 2021.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09383-8","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:54:14Z","timestamp":1766987654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Memantine and graded motor imagery for complex regional pain syndrome (MEMOIR): study protocol and statistical analysis plan for a decentralised, 2\u2009\u00d7\u20092 factorial randomised trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-1832","authenticated-orcid":false,"given":"Michael C.","family":"Ferraro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick L.","family":"Gilanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Lorimer","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict M.","family":"Wand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil E.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hopin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia M.","family":"Gustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan G.","family":"Cashin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"9","key":"9383_CR1","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1097\/j.pain.0000000000002245","volume":"162","author":"A Goebel","year":"2021","unstructured":"Goebel A, Birklein F, Brunner F, Clark JD, Gierthm\u00fchlen J, Harden N, et al. The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria. Pain. 2021;162(9):2346\u20138.","journal-title":"Pain."},{"key":"9383_CR2","unstructured":"WHOFIC Foundation. [cited 2025 Jan 6]. Available from: https:\/\/icd.who.int\/browse\/2024-01\/foundation\/en#1834504950."},{"issue":"5","key":"9383_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S1474-4422(24)00076-0","volume":"23","author":"MC Ferraro","year":"2024","unstructured":"Ferraro MC, O\u2019Connell NE, Sommer C, Goebel A, Bultitude JH, Cashin AG, et al. Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatment. Lancet Neurol. 2024;23(5):522\u201333.","journal-title":"Lancet Neurol"},{"issue":"1","key":"9383_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","volume":"160","author":"RD Treede","year":"2019","unstructured":"Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19\u201327.","journal-title":"Pain"},{"key":"9383_CR5","doi-asserted-by":"crossref","unstructured":"Sandroni P, Benrud-Larson LM, McClelland RL, et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based study. Pain. 2003;103:199\u2013207.","DOI":"10.1016\/S0304-3959(03)00065-4"},{"issue":"1","key":"9383_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pain.2006.09.008","volume":"129","author":"M de Mos","year":"2007","unstructured":"de Mos M, de Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker BHC, Sturkenboom MCJM. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129(1):12\u201320.","journal-title":"Pain"},{"key":"9383_CR7","unstructured":"Commissioner of the FDA. FDA; 2024 [cited 2025 Jan 6]. Rare diseases at FDA. Available from: https:\/\/www.fda.gov\/patients\/rare-diseases-fda."},{"key":"9383_CR8","unstructured":"Orphan designation: overview | European Medicines Agency (EMA). 2024 [cited 2025 Jan 6]. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/orphan-designation-overview."},{"issue":"6","key":"9383_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ejp.813","volume":"20","author":"DJ Bean","year":"2016","unstructured":"Bean DJ, Johnson MH, Heiss-Dunlop W, Kydd RR. Extent of recovery in the first 12 months of complex regional pain syndrome type-1: a prospective study. Eur J Pain. 2016;20(6):884\u201394.","journal-title":"Eur J Pain"},{"issue":"9","key":"9383_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/ejp.1064","volume":"21","author":"F Brunner","year":"2017","unstructured":"Brunner F, Bachmann LM, Perez RSGM, Marinus J, Wertli MM. Painful swelling after a noxious event and the development of complex regional pain syndrome 1: a one-year prospective study. Eur J Pain. 2017;21(9):1611\u20137.","journal-title":"Eur J Pain"},{"issue":"6","key":"9383_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/ejp.1953","volume":"26","author":"S Johnson","year":"2022","unstructured":"Johnson S, Cowell F, Gillespie S, Goebel A. Complex regional pain syndrome what is the outcome? - a systematic review of the course and impact of CRPS at 12 months from symptom onset and beyond. Eur J Pain. 2022;26(6):1203\u201320.","journal-title":"Eur J Pain"},{"issue":"3","key":"9383_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3344\/kjp.2021.34.3.288","volume":"34","author":"J Lee","year":"2021","unstructured":"Lee J, Lim YH, Hong SJ, Jeong JH, Choi HR, Park SK, et al. Multicenter survey of symptoms, work life, economic status, and quality of life of complex regional pain syndrome patients. Korean J Pain. 2021;34(3):288\u2013303.","journal-title":"Korean J Pain"},{"key":"9383_CR13","doi-asserted-by":"crossref","unstructured":"Lyckeg\u00e5rd Finn E, Parinder A, Nyman E, Dahlin Lars B. Complex regional pain syndrome: a cross-sectional study of physical symptoms, disability, and psychological health in long term. Pain Rep. 2024;9(5):e1180.","DOI":"10.1097\/PR9.0000000000001180"},{"issue":"8","key":"9383_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2217\/pmt-2022-0046","volume":"12","author":"S Javed","year":"2022","unstructured":"Javed S, Kang WD, Black C, Chorath K, Johal J, Huh BK. Clinical practice guidelines for the management of patients with complex regional pain syndrome: a systematic appraisal using the AGREE II instrument. Pain Manag. 2022;12(8):951\u201360.","journal-title":"Pain Manag"},{"key":"9383_CR15","doi-asserted-by":"crossref","unstructured":"Ferraro MC, Cashin AG, Wand BM, Smart KM, Berryman C, Marston L, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome - an overview of systematic reviews. Cochrane Database Syst Rev. 2023;(6):CD009416.","DOI":"10.1002\/14651858.CD009416.pub3"},{"issue":"1","key":"9383_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2010.06.022","volume":"151","author":"SM Gustin","year":"2010","unstructured":"Gustin SM, Schwarz A, Birbaumer N, Sines N, Schmidt AC, Veit R, et al. NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain. 2010;151(1):69\u201376.","journal-title":"Pain"},{"issue":"1","key":"9383_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pain.2004.01.006","volume":"108","author":"LG Moseley","year":"2004","unstructured":"Moseley LG. Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial. Pain. 2004;108(1):192\u20138.","journal-title":"Pain"},{"issue":"12","key":"9383_CR18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1212\/01.wnl.0000249112.56935.32","volume":"67","author":"GL Moseley","year":"2006","unstructured":"Moseley GL. Graded motor imagery for pathologic pain: a randomized controlled trial. Neurology. 2006;67(12):2129\u201334.","journal-title":"Neurology"},{"key":"9383_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","volume":"33","author":"D Kreutzwiser","year":"2019","unstructured":"Kreutzwiser D, Tawfic QA. Expanding role of NMDA receptor antagonists in the management of pain. CNS Drugs. 2019;33:347\u201374.","journal-title":"CNS Drugs"},{"issue":"5","key":"9383_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1399-6576.2008.01638.x","volume":"52","author":"F Wesseldijk","year":"2008","unstructured":"Wesseldijk F, Fekkes D, Huygen FJPM, Van De Heide\u2010Mulder M, Zijlstra FJ. Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1. Acta Anaesthesiol Scand. 2008;52(5):688\u201394.","journal-title":"Acta Anaesthesiol Scand"},{"key":"9383_CR21","doi-asserted-by":"crossref","unstructured":"Ferraro MC, Cashin AG, Visser EJ, Abdel Shaheed C, Wewege MA, Wand BM, et al. Ketamine and other NMDA receptor antagonists for chronic pain. Cochrane Database Syst Rev. 2025(8):CD015373.","DOI":"10.1002\/14651858.CD015373.pub2"},{"issue":"9","key":"9383_CR22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jpain.2022.04.008","volume":"23","author":"M Lotze","year":"2022","unstructured":"Lotze M, Moseley GL. Clinical and neurophysiological effects of progressive movement imagery training for pathological pain. J Pain. 2022;23(9):1480\u201391.","journal-title":"J Pain"},{"key":"9383_CR23","volume":"5","author":"KM Smart","year":"2022","unstructured":"Smart KM, Ferraro MC, Wand BM, O\u2019Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2022;5:CD010853.","journal-title":"Cochrane Database Syst Rev"},{"key":"9383_CR24","volume-title":"Complex regional pain syndrome in adults UK guidelines for diagnosis, referral and management in primary and secondary care","author":"A Goebel","year":"2018","unstructured":"Goebel A, Barker CH, Turner-Stokes L, et al. Complex regional pain syndrome in adults UK guidelines for diagnosis, referral and management in primary and secondary care. London: Royal College of Physicians; 2018."},{"issue":"Suppl 1","key":"9383_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/pm\/pnac046","volume":"23","author":"RN Harden","year":"2022","unstructured":"Harden RN, McCabe CS, Goebel A, Suvar T, Grieve S, Bruehl S. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 5th edition. Pain Med. 2022;23(Suppl 1):S1-53.","journal-title":"Pain Med"},{"key":"9383_CR26","volume-title":"Updated guidelines: complex regional pain syndrome type I","author":"R Perez","year":"2014","unstructured":"Perez R, Geertzen J, Dijkstra P, Dirckx M, van Eijs F, Fr\u00f6lke J. Updated guidelines: complex regional pain syndrome type I. Netherlands: Netherlands Society of Anaesthesiologists\/Netherlands Society of Rehabilitation Specialists; 2014."},{"key":"9383_CR27","unstructured":"Birklein F, Oschmann P, Schattschneider J, Sommer C, Baron R, Gierthm\u00fchlen J, et al. Diagnostik und therapie komplexer regionaler schmerzsyndrome (CRPS): S1-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (DGN), editor. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Berlin: DGN; 2018."},{"issue":"3","key":"9383_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"21","key":"9383_CR29","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1001\/jama.2023.19793","volume":"330","author":"BC Kahan","year":"2023","unstructured":"Kahan BC, Hall SS, Beller EM, Birchenall M, Chan AW, Elbourne D, et al. Reporting of factorial randomized trials: extension of the CONSORT 2010 statement. JAMA. 2023;330(21):2106\u201314.","journal-title":"JAMA"},{"issue":"23","key":"9383_CR30","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","volume":"318","author":"C Gamble","year":"2017","unstructured":"Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dor\u00e9 C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318(23):2337\u201343.","journal-title":"JAMA"},{"key":"9383_CR31","unstructured":"European Medicines Agency. Recommendation paper on decentralised elements in clinical trials. 2022. Available from: https:\/\/health.ec.europa.eu\/latest-updates\/recommendation-paper-decentralised-elements-clinical-trials-2022-12-14_en."},{"issue":"10385","key":"9383_CR32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(23)00463-4","volume":"401","author":"M Al","year":"2023","unstructured":"Al M, Levison S, Berdel WE, Andersen DZ. Decentralised elements in clinical trials: recommendations from the European Medicines Regulatory Network. Lancet. 2023;401(10385):1339.","journal-title":"Lancet"},{"issue":"6","key":"9383_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"2","key":"9383_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"9383_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"9383_CR36","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH harmonised guideline: integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2). 2016."},{"issue":"6","key":"9383_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/j.pain.0000000000000866","volume":"158","author":"S Grieve","year":"2017","unstructured":"Grieve S, Perez RSGM, Birklein F, Brunner F, Bruehl S, Harden RN, et al. Recommendations for a first core outcome measurement set for complex regional PAin syndrome clinical studies (COMPACT). Pain. 2017;158(6):1083\u201390.","journal-title":"Pain"},{"issue":"2","key":"9383_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0304-3959(92)90154-4","volume":"50","author":"M Von Korff","year":"1992","unstructured":"Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133\u201349.","journal-title":"Pain"},{"issue":"2","key":"9383_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3959(99)00101-3","volume":"83","author":"MP Jensen","year":"1999","unstructured":"Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999;83(2):157\u201362.","journal-title":"Pain"},{"issue":"1","key":"9383_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2010.04.025","volume":"150","author":"D Amtmann","year":"2010","unstructured":"Amtmann D, Cook KF, Jensen MP, Chen WH, Choi S, Revicki D, et al. Development of a PROMIS item bank to measure pain interference. Pain. 2010;150(1):173\u201382.","journal-title":"Pain"},{"key":"9383_CR41","doi-asserted-by":"crossref","unstructured":"Askew RL, Cook KF, Revicki DA, Cella D, Amtmann D. Evidence from diverse clinical populations supported clinical validity of PROMIS pain interference and pain behavior. J Clin Epidemiol. 2016;73:103\u201311.","DOI":"10.1016\/j.jclinepi.2015.08.035"},{"issue":"5","key":"9383_CR42","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jclinepi.2013.10.024","volume":"67","author":"M Rose","year":"2014","unstructured":"Rose M, Bjorner JB, Gandek B, Bruce B, Fries JF, Ware JE. The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. J Clin Epidemiol. 2014;67(5):516\u201326.","journal-title":"J Clin Epidemiol"},{"issue":"10 Suppl","key":"9383_CR43","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.apmr.2010.08.033","volume":"92","author":"JS Lai","year":"2011","unstructured":"Lai JS, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011;92(10 Suppl):S20\u20137.","journal-title":"Arch Phys Med Rehabil"},{"issue":"7","key":"9383_CR44","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s11136-017-1527-3","volume":"26","author":"AL Gruber-Baldini","year":"2017","unstructured":"Gruber-Baldini AL, Velozo C, Romero S, Shulman LM. Validation of the PROMIS\u00ae measures of self-efficacy for managing chronic conditions. Qual Life Res. 2017;26(7):1915\u201324.","journal-title":"Qual Life Res"},{"issue":"10","key":"9383_CR45","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/pon.3522","volume":"23","author":"JS Lai","year":"2014","unstructured":"Lai JS, Wagner LI, Jacobsen PB, Cella D. Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncol. 2014;23(10):1133\u201341.","journal-title":"Psychooncol"},{"issue":"3","key":"9383_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1073191111411667","volume":"18","author":"PA Pilkonis","year":"2011","unstructured":"Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D. Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS\u00ae): depression, anxiety, and anger. Assessment. 2011;18(3):263\u201383.","journal-title":"Assessment"},{"issue":"9","key":"9383_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s11136-010-9694-5","volume":"19","author":"WT Riley","year":"2010","unstructured":"Riley WT, Rothrock N, Bruce B, Christodolou C, Cook K, Hahn EA, et al. Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks. Qual Life Res. 2010;19(9):1311\u201321.","journal-title":"Qual Life Res"},{"issue":"2","key":"9383_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jpain.2014.11.002","volume":"16","author":"MK Nicholas","year":"2015","unstructured":"Nicholas MK, McGuire BE, Asghari A. A 2-item short form of the pain self-efficacy questionnaire: development and psychometric evaluation of PSEQ-2. J Pain. 2015;16(2):153\u201363.","journal-title":"J Pain"},{"issue":"3","key":"9383_CR49","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.pain.2010.09.031","volume":"151","author":"RN Harden","year":"2010","unstructured":"Harden RN, Bruehl S, Perez RSGM, Birklein F, Marinus J, Maihofner C, et al. Development of a severity score for CRPS. Pain. 2010;151(3):870\u20136.","journal-title":"Pain"},{"issue":"8","key":"9383_CR50","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/j.pain.0000000000000927","volume":"158","author":"R Norman Harden","year":"2017","unstructured":"Norman Harden R, Maihofner C, Abousaad E, Vatine JJ, Kirsling A, Perez RSGM, et al. A prospective, multisite, international validation of the complex regional pain syndrome severity score. Pain. 2017;158(8):1430\u20132143.","journal-title":"Pain"},{"issue":"11","key":"9383_CR51","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jclinepi.2009.11.021","volume":"63","author":"H Liu","year":"2010","unstructured":"Liu H, Cella D, Gershon R, Shen J, Morales LS, Riley W, et al. Representativeness of the PROMIS Internet Panel. J Clin Epidemiol. 2010;63(11):1169\u201378.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"9383_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/BOT.0000000000000059","volume":"28","author":"M Hung","year":"2014","unstructured":"Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN. Computerized adaptive testing using the PROMIS physical function item bank reduces test burden with less ceiling effects compared with the short musculoskeletal function assessment in orthopaedic trauma patients. J Orthop Trauma. 2014;28(8):439\u201343.","journal-title":"J Orthop Trauma"},{"issue":"2","key":"9383_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","volume":"31","author":"GJ Devilly","year":"2000","unstructured":"Devilly GJ, Borkovec TD. Psychometric properties of the credibility\/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73\u201386.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"8","key":"9383_CR54","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"9383_CR55","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3899\/jrheum.141440","volume":"42","author":"JW Busse","year":"2015","unstructured":"Busse JW, Bartlett SJ, Dougados M, Johnston BC, Guyatt GH, Kirwan JR, et al. Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 workshop. J Rheumatol. 2015;42(10):1962\u201370.","journal-title":"J Rheumatol"},{"key":"9383_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/1745-6215-15-404","volume":"15","author":"A Goebel","year":"2014","unstructured":"Goebel A, Shenker N, Padfield N, Shoukrey K, McCabe C, Serpell M, et al. Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial. Trials. 2014;15:404.","journal-title":"Trials"},{"key":"9383_CR57","doi-asserted-by":"crossref","unstructured":"Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond \u201cp < 0.05.\u201d Am Stat. 2019;73(sup1):1\u201319.","DOI":"10.1080\/00031305.2019.1583913"},{"issue":"10489","key":"9383_CR58","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","volume":"405","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. Lancet. 2025;405(10489):1633\u201340.","journal-title":"Lancet"},{"issue":"22","key":"9383_CR59","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1002\/sim.9510","volume":"41","author":"BC Kahan","year":"2022","unstructured":"Kahan BC, Morris TP, Goul\u00e3o B, Carpenter J. Estimands for factorial trials. Stat Med. 2022;41(22):4299\u2013310.","journal-title":"Stat Med"},{"issue":"1","key":"9383_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41687-023-00677-6","volume":"8","author":"RD Hays","year":"2024","unstructured":"Hays RD, Herman PM, Qureshi N, Rodriguez A, Edelen MO. Mapping of the PROMIS global health measure to the PROPr in the United States. J Patient Rep Outcomes. 2024;8(1):5.","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"9383_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-021-02204-0","volume":"20","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022;20(1):23.","journal-title":"BMC Med"},{"issue":"11","key":"9383_CR62","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jama.2021.14075","volume":"326","author":"H Lee","year":"2021","unstructured":"Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, et al. A guideline for reporting mediation analyses of randomized trials and observational studies: the AGReMA statement. JAMA. 2021;326(11):1045\u201356.","journal-title":"JAMA"},{"key":"9383_CR63","doi-asserted-by":"publisher","DOI":"10.2307\/2291054","author":"JD Angrist","year":"1995","unstructured":"Angrist JD, Imbens GW. Two-stage least squares estimation of average causal effects in models with variable treatment intensity. J Am Stat Assoc. 1995. https:\/\/doi.org\/10.2307\/2291054.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"9383_CR64","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11121-008-0104-y","volume":"9","author":"EA Stuart","year":"2008","unstructured":"Stuart EA, Perry DF, Le HN, Ialongo NS. Estimating intervention effects of prevention programs: accounting for noncompliance. Prev Sci. 2008;9(4):288\u201398.","journal-title":"Prev Sci"},{"key":"9383_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. 1st ed. Wiley; 1987.","edition":"1st ed"},{"issue":"3","key":"9383_CR66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1536867X0400400301","volume":"4","author":"P Royston","year":"2004","unstructured":"Royston P. Multiple imputation of missing values. The Stata Journal: Promoting communications on statistics and Stata. 2004;4(3):227\u201341.","journal-title":"The Stata Journal: Promoting communications on statistics and Stata"},{"issue":"7","key":"9383_CR67","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/ejp.1976","volume":"26","author":"E Moore","year":"2022","unstructured":"Moore E, Braithwaite FA, Stanton TR, Bellan V, Moseley GL, Berryman C. What do I need to know? Essential educational concepts for complex regional pain syndrome. Eur J Pain. 2022;26(7):1481\u201398.","journal-title":"Eur J Pain"},{"key":"9383_CR68","volume-title":"Safety monitoring and reporting in clinical trials involving therapeutic goods","author":"National Health and Medical Research Council (NHMRC)","year":"2016","unstructured":"National Health and Medical Research Council (NHMRC). Safety monitoring and reporting in clinical trials involving therapeutic goods. Canberra: NHMRC; 2016."},{"key":"9383_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDier) checklist and guide. BMJ. 2014;348:g1687.","journal-title":"BMJ"},{"issue":"6711","key":"9383_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq4994","volume":"385","author":"G Jean-Louis","year":"2024","unstructured":"Jean-Louis G, Seixas AA. The value of decentralized clinical trials: inclusion, accessibility, and innovation. Science. 2024;385(6711):eadq4994.","journal-title":"Science"},{"issue":"1","key":"9383_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00603-y","volume":"5","author":"N Goodson","year":"2022","unstructured":"Goodson N, Wicks P, Morgan J, Hashem L, Callinan S, Reites J. Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion. NPJ Digit Med. 2022;5(1):58.","journal-title":"NPJ Digit Med"},{"key":"9383_CR72","doi-asserted-by":"crossref","unstructured":"Smart KM, Abbott-Fleming V, Birklein F, et al. Optimising clinical trial methods for complex regional pain syndrome: a methodological framework (OptiMeth-CRPS). Pain Reports. 2025;10(6):e1320.","DOI":"10.1097\/PR9.0000000000001320"},{"issue":"1","key":"9383_CR73","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1172-8-48","volume":"8","author":"C Cornu","year":"2013","unstructured":"Cornu C, Kassai B, Fisch R, Chiron C, Alberti C, Guerrini R, et al. Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis. 2013;8(1):48.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09383-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09383-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09383-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:03:05Z","timestamp":1770285785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09383-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9383"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09383-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Sydney Local Health District RPA Research Ethics and Governance office on 13 October 2020 (X20-0325 and 2020\/ETH01743). Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"No identifying images or other identifying personal or clinical details of participants are presented here or will be presented in reports of the trial results. Participant information sheets and consent forms are available from the corresponding author on request. All authors listed above meet the authorship criteria according to the latest guidelines of the International Committee of Medical Journal Editors, and all authors agree with the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"MF is a member of the IASP CRPS, and Methodology, Evidence Synthesis and Implementation Special Interest Groups. AM receives research funding from the NHMRC, and the Sydney Pharmacy School receives research scholarship funding from GSK for a PhD student under his supervision. AM has served as a paid consultant on Australian government committees related to medicines regulation. NOC was Coordinating Editor of the Cochrane Pain, Palliative and Supportive Care group (2020\u20132023), whose activities were funded by The UK National Institute of Health and Care Research (NIHR). He is the chair of the IASP Methodology, Evidence Synthesis and Implementation Special Interest Group and has held a grant from the ERA-NET Neuron Co-Fund. GLM has received support from Reality Health, ConnectHealth UK, Institutes of Health California, AIA Australia, Workers\u2019 Compensation Boards, and professional sporting organisations in Australia, Europe, South and North America. Professional and scientific bodies have reimbursed him for travel costs related to the presentation of research on CRPS, pain, and pain education at scientific conferences\/symposia. He has received speaker fees for lectures on CRPS, pain, pain education, and rehabilitation. He receives royalties for books on CRPS, pain, and pain education. He is the non-paid CEO of the non-profit Pain Revolution. He developed graded motor imagery, one of the treatments being tested in this trial. He will have no role in data collection nor analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"107"}}